Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.53 -0.06 (-1.81%)
As of: Oct 1, 2026 · 12:42 PM EDT

Insight Molecular Diagnostics (IMDX) Other Non-Current Liabilities (2019 - 2026)

Updated

Insight Molecular Diagnostics (IMDX) posted Other Non-Current Liabilities of $39.54 million for Q2 2026, down 3.4% from $40.93 million a year earlier but up 4.6% from the prior quarter.

Analysis

Insight Molecular Diagnostics (IMDX) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Insight Molecular Diagnostics' Other Non-Current Liabilities came in at $43.46 million, up 15.2% from FY2024.

  • Annual Other Non-Current Liabilities shows a five-year compound annual growth rate of 43.6% (FY2020 to FY2025).
  • In prior years, Insight Molecular Diagnostics' Other Non-Current Liabilities was $37.71 million in FY2024 (-5.5%), $39.9 million in FY2023 (-12.6%), $45.66 million in FY2022 (-40.5%) and $76.68 million in FY2021 (+977.0%).
  • Quarterly Other Non-Current Liabilities has run from a low of $27.36 million in Q1 2023 to a high of $76.68 million in Q4 2021 over five years.
  • On a year-over-year basis, Other Non-Current Liabilities increased in two of the last eight quarters, with growth averaging 6.3%.
  • The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was Q4 2021, with growth of 977.0%; the weakest was Q1 2023, with a decline of 62.0%.
  • According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $37.81 million (Q1 2026), $43.46 million (Q4 2025) and $43.94 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Insight Molecular Diagnostics 117.12 Mn 40.83 Mn 157,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.54 Mn
Mar 31, 2026 37.81 Mn
Dec 31, 2025 43.46 Mn
Sep 30, 2025 43.94 Mn
Jun 30, 2025 40.93 Mn
Mar 31, 2025 38.39 Mn
Dec 31, 2024 37.71 Mn
Sep 30, 2024 48.71 Mn
Jun 30, 2024 42.18 Mn
Mar 31, 2024 43.21 Mn
Dec 31, 2023 39.90 Mn
Sep 30, 2023 28.72 Mn
Jun 30, 2023 29.15 Mn
Mar 31, 2023 27.36 Mn
Dec 31, 2022 45.66 Mn
Sep 30, 2022 59.52 Mn
Jun 30, 2022 65.67 Mn
Mar 31, 2022 72.03 Mn
Dec 31, 2021 76.68 Mn
Sep 30, 2021 51.68 Mn
API Access

Insight Molecular Diagnostics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=IMDX&period=max&api_key=YOUR_API_KEY